UK Remote Patient Monitoring (RPM) Market (2026-2031)
The UK Remote Patient Monitoring (RPM) Market was valued at $25427.1 Million in 2026 and projected to reach to $45098.3 Million by 2031, representing a compound annual growth rate of 12.1%. The UK Remote Patient Monitoring market is positioned for sustained expansion through 2031, supported by NHS long-term plans emphasizing digital-first care delivery and integrated care systems.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
UK Remote Patient Monitoring (RPM) Market Trends and Insights
- Devices encompass wearable sensors, monitoring equipment, and connected hardware that enable continuous patient data collection and transmission to healthcare providers.
- This segment is experiencing robust expansion, driven by increasing adoption of telehealth solutions, rising prevalence of chronic diseases, and technological advancements in miniaturization and wireless connectivity. Devices are projected to grow substantially to $45,098.3 million by 2031, reflecting a compound annual growth rate (CAGR) of 12.1%.
- This growth trajectory underscores the fundamental role Devices play in enabling remote monitoring capabilities across diverse patient populations and clinical settings.
- The expansion of Devices is supported by favorable reimbursement policies, integration with electronic health records (EHR) systems, and growing consumer demand for personalized health management solutions. Devices continue to evolve with enhanced battery life, improved accuracy, and seamless interoperability standards, positioning them as essential enablers of the broader RPM ecosystem.
- Market participants are investing heavily in next-generation Devices to capture growing demand from both developed and emerging markets..
Key Market Statistics
- CAGR (2026-2031) 12.1% CAGR
- Market Size, 2026 ~USD 25427.1 Million
- Forecast, 2031 ~USD 45098.3 Million
- Country UK
UK Remote Patient Monitoring (RPM) Market Overview
UK Market Valuation :
The UK Remote Patient Monitoring market is valued at $25,427.1 million in 2026, with strong growth trajectory driven by NHS digital transformation initiatives and increasing adoption of connected health devices across the National Health Service.
Robust Growth Trajectory :
The UK RPM market is projected to reach $45,098.3 million by 2031, representing a 12.1% CAGR. This growth outpaces many European markets, reflecting the UK's commitment to digital health infrastructure and remote care delivery models.
Device Segment Leadership :
Wearable sensors and connected monitoring equipment dominate the UK RPM landscape, enabling continuous patient data collection. NHS trusts are increasingly investing in these devices to support chronic disease management and reduce hospital readmissions.
Healthcare Provider Adoption :
UK healthcare providers are rapidly integrating RPM solutions to enhance patient outcomes and operational efficiency. Integration with existing NHS systems and compliance with UK data protection regulations are driving standardized device deployment across primary and secondary care.
UK Remote Patient Monitoring (RPM) Market Dynamics
- Government funding for digital health infrastructure, combined with aging population demographics and rising chronic disease prevalence, creates strong demand for RPM devices and monitoring solutions.
- Healthcare providers are increasingly recognizing RPM's potential to improve patient engagement and reduce healthcare costs. Key growth drivers include regulatory support from NICE guidelines, reimbursement pathways for remote monitoring services, and integration with electronic health records across NHS trusts.
- The UK's advanced healthcare infrastructure and digital literacy provide competitive advantages for RPM adoption.
- However, cybersecurity concerns, data interoperability challenges, and varying adoption rates across regions may moderate growth.
- Strategic partnerships between device manufacturers and NHS providers will be critical for market expansion..
Related Ecosystem
Cardiovascular Devices
- External Defibrillators
- Implantable Cardioverter Defibrillators
- Pulse Oximeters
- Robotic Systems
- 3-Lead ECG Leadwires
- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- Terumo Corporation
- KONINKLIJKE PHILIPS N.V.
Diagnostic Imaging
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- CT Scanners
- Nuclear Imaging
- Positron Emission Tomography
- Siemens healthineers
- PHILIPS HEALTHCARE
- CANON INC.
- FUJIFILM Holdings Corporation
- UNITED IMAGING HEALTHCARE CO., LTD.
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Key Takeaways
- Devices segment valued at $25.4B in 2026, expanding to $45.1B by 2031 at 12.1% CAGR
- Devices include wearables, sensors, and connected hardware enabling continuous patient monitoring and data transmission
- Growth in Devices driven by chronic disease prevalence, telehealth adoption, and technological miniaturization advances
- Devices benefit from improved reimbursement policies and EHR integration, supporting market expansion through 2031
Remote Patient Monitoring (RPM) Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | ASIA PACIFIC (Indication) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 12.8% from 2026 to 2031 |
| Largest Segment | DEVICES (Component) |
| Market Size Base Year (Billions) | ~USD 36.32 (2026) |
| Revenue Forecast (Billions) | ~USD 66.33 (2031) |
| Segments Covered | Component, Function, Type, Deployment Model, Transmission Type, Indication, End User, Deployment Type |
UK Remote Patient Monitoring (RPM) Market Report Segmentation
8 segment dimensions are covered across the global market.
By Component
- Devices
- Services
- Software
By Function
- Blood Glucose Monitoring
- Blood Glucose Monitoring Devices
- Cardiac Monitoring
- Cardiac Monitoring Devices
- Fetal & Neonatal Monitoring
- Fetal & Neonatal Monitoring Devices
- Multiparameter Monitoring
- Multiparameter Monitoring Devices
- Neurological Monitoring
- Neurological Monitoring Devices
- Other Monitoring Devices
- Pulse Oximeter Devices
- Pulse Oximeters
- Respiratory Monitoring
- Respiratory Monitoring Devices
- Thermometers
- Weight Monitoring
- Weight Monitoring Devices
By Type
- Ambulatory Surgical Centers, Ambulatory Care Centers, And Other Outpatient Settings
- Ascs, Accs, And Other Outpatient Settings
- Handheld & Portable Devices
- Home Healthcare
- Hospitals
- Implantable Devices
- Long-Term Care & Assisted Living Facilities
- Other Devices
- Other Healthcare Providers
- Wearable Devices
By Deployment Model
- Cloud-Based Models
- On-Premise Models
By Transmission Type
- Asynchronous
- Synchronous
By Indication
- Cardiology
- Diabetes
- Mental Health
- Neurology
- Oncology
- Other Indications
- Respiratory Disorders
- Sleep Disorders
- Wellness Improvement
By End User
- Healthcare Payers
- Healthcare Providers
- Medtech Companies
- Other End Users
- Patients
- Pharmaceutical & Biotechnology Companies
By Deployment Type
- Cloud-Based Models
- On-Premise Models
Target Audience
- NHS Trust Procurement Teams : Need comprehensive market data to evaluate RPM device vendors, understand competitive offerings, and justify capital investments in digital health infrastructure aligned with NHS long-term plans and integrated care system requirements.
- Medical Device Manufacturers : Require UK-specific market intelligence to develop go-to-market strategies, identify partnership opportunities with NHS providers, and understand regulatory pathways for device approval and reimbursement in the British healthcare system.
- Healthcare Technology Investors : Need detailed market forecasts and growth projections to identify investment opportunities in UK RPM companies, assess market attractiveness, and evaluate exit potential within the rapidly expanding digital health sector.
- Digital Health Consultants : Require authoritative UK market data to advise healthcare organizations on RPM adoption strategies, vendor selection, and implementation roadmaps aligned with NHS digital transformation priorities and clinical outcomes.
- Private Healthcare Providers : Need competitive market insights to develop RPM service offerings, understand patient demand for remote monitoring, and identify partnership opportunities with device manufacturers and technology platforms in the UK market.
Key Companies in the UK Remote Patient Monitoring (RPM) Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KONINKLIJKE PHILIPS N.V. | Netherlands | Public Company | Diagnosis & Treatment (Imaging and Image Guided Therapy),Connected Care (Monitoring, Enterprise Informatics, Sleep and Respiratory Care),Personal Health, |
| MEDTRONIC | Ireland | Public Company | Cardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes and Monitoring), |
| GE HEALTHCARE | United States | Public Company | Imaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS), |
| ABBOTT | United States | Public Company | Diagnostic Products,Medical Devices,Nutritional Products, |
| ORACLE | United States | Public Company | Cloud Applications (Fusion ERP/EPM/SCM/HCM, NetSuite, CX, Health),Database and Infrastructure Technologies (Oracle DB, MySQL, Autonomous, Middleware, Java),Cloud Infrastructure (Compute, Storage, Networking, AI/ML, Digital Assistant, Blockchain), |
| BOSTON SCIENTIFIC CORPORATION | United States | Public Company | Cardiovascular (structural heart, CRM, LAAC, peripheral interventions),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health, |
| NIHON KOHDEN CORPORATION | Japan | Public Company | Patient monitors and clinical information systems,Physiological measuring equipment (EEG, ECG, EMG, polygraphs),Defibrillators, AEDs, and resuscitation devices, |
| SIEMENS HEALTHINEERS AG | Germany | Public Company | Imaging,Diagnostics,Varian (Oncology), |
| BAXTER | United States | Public Company | Medical Products & Therapies (IV solutions, infusion, parenteral nutrition, renal and related therapies),Healthcare Systems & Technologies (smart beds, monitoring, OR integration, surgical equipment, respiratory devices),Pharmaceuticals (generic and specialty injectables, inhaled anesthetics, compounding services), |
KONINKLIJKE PHILIPS N.V.
Koninklijke Philips N.V. is a Dutch multinational public company founded in 1891 with 64,317 employees, operating across healthcare and technology sectors.
MEDTRONIC
Medtronic is a public medical technology company founded in 1949 in Ireland with 95,000 employees, providing medical devices and healthcare solutions.
GE HEALTHCARE
GE Healthcare is a public healthcare company established in 2022 in the United States with 54,000 employees, offering medical imaging and healthcare technology.
ABBOTT
Abbott is a public healthcare and diagnostics company founded in 1888 in the United States with 115,000 employees.
ORACLE
Oracle is a public software and cloud computing company founded in 1977 in the United States with 141,000 employees.
BOSTON SCIENTIFIC CORPORATION
Boston Scientific Corporation is a public medical device company founded in 1979 in the United States with 59,000 employees.
NIHON KOHDEN CORPORATION
Nihon Kohden Corporation is a Japanese public company founded in 1951 with 6,116 employees, specializing in medical equipment and healthcare technology.
SIEMENS HEALTHINEERS AG
Siemens Healthineers AG is a German public healthcare company founded in 1896 with 72,369 employees, providing medical imaging and diagnostic solutions.
BAXTER
Baxter is a public healthcare company founded in 1931 in the United States with 37,500 employees, specializing in medical devices and pharmaceuticals.
Reasons to Buy this Report
- UK-Specific Market Sizing : Access precise valuation data for the UK RPM market with detailed forecasts through 2031. Understand market size dynamics specific to the British healthcare system, NHS procurement patterns, and regional variations across England, Scotland, Wales, and Northern Ireland.
- Competitive Landscape Intelligence : Identify leading device manufacturers, healthcare providers, and technology partners operating in the UK market. Benchmark your position against competitors and understand market consolidation trends specific to the UK healthcare sector.
- NHS Integration Insights : Gain actionable intelligence on NHS adoption strategies, integration requirements with existing systems, and procurement frameworks. Understand how NHS trusts evaluate and deploy RPM solutions across integrated care systems.
- Regulatory & Reimbursement Pathways : Navigate UK-specific regulatory requirements, NICE guidance, and reimbursement models for RPM services. Understand compliance obligations and pathways to market access within the British healthcare system.
- Growth Opportunity Assessment : Evaluate expansion opportunities across UK regions, identify underserved patient populations, and assess demand for specific device types. Make informed investment and partnership decisions based on UK market dynamics and demographic trends.
Frequently asked questions
What types of products are included in the Devices segment?
The Devices segment encompasses wearable sensors, vital sign monitors, connected diagnostic equipment, smartwatches, patches, and other hardware that collect and transmit patient health data in real-time for remote monitoring purposes.
What is the projected market size for Devices in 2031?
The Devices segment is forecasted to reach $45,098.3 million by 2031, growing from $25,427.1 million in 2026 at a CAGR of 12.1%.
What factors are driving growth in the Devices market?
Key growth drivers for Devices include rising chronic disease prevalence, increased telehealth adoption, technological advancements in miniaturization and battery life, favorable reimbursement policies, and growing consumer demand for personalized health management.
How do Devices integrate with broader RPM ecosystems?
Devices serve as the foundational hardware layer in RPM systems, collecting patient data and transmitting it to cloud platforms and EHR systems where software and analytics components process and present insights to healthcare providers.
Which regions are expected to drive Devices market growth?
Both developed markets with established healthcare infrastructure and emerging markets with growing digital health adoption are expected to drive Devices growth, supported by improving connectivity and healthcare spending.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the remote patient monitoring market.
Exhaustive secondary research was done to collect information on the remote patient monitoring industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the remote patient monitoring market.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for the study of the remote patient monitoring market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global remote patient monitoring market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions—North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
BREAKDOWN OF PRIMARY INTERVIEW PARTICIPANTS
Note 1: Others include sales managers, marketing managers, and product managers.
Note 2: Tiers of companies are defined on the basis of their total revenues in 2025. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the remote patient monitoring market. These methods were also used extensively to estimate the size of various subsegments in the market.
The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the remote patient monitoring market.
Market Definition
The remote patient monitoring (RPM) market involves the use of technology to remotely monitor and manage patients' health conditions outside of traditional healthcare settings, as well as in patient settings. It leverages devices such as wearables, sensors, and mobile applications to track vital signs and chronic diseases. RPM allows healthcare providers to access real-time data for better decision-making and personalized care.
Key Stakeholders
- RPM Equipment and devices Manufacturers
- Suppliers and Distributors of RPM Equipment
- RPM software provider
- Healthcare IT Service Providers
- Healthcare Insurance Companies/Payers
- Healthcare Institutions/Providers (Hospitals, Clinics, Medical Groups, Physician Practices, Diagnostic Centers, and Outpatient Clinics)
- Venture Capitalists
- Government Bodies/Regulatory Bodies
- Corporate Entities
- Accountable Care Organizations
- RPM Resource Centers
- Research and Consulting Firms
- Medical Research Institutes
- Clinical Departments
Report Objectives
- To define, describe, and forecast the global remote patient monitoring market based on component, indication, end user, and region.
- To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
- To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall remote patient monitoring market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
- To strategically analyze the market structure profile of the key players of the remote patient monitoring market and comprehensively analyze their core competencies.
- To forecast the size of the market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
- To track and analyze competitive developments such as product launches and enhancements, investments, partnerships, collaborations, acquisitions, expansions, funding, grants, agreements, sales contracts, product testing, FDA approval, product approval, and alliances in the remote patient monitoring market during the forecast period.
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
- Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company.
- Geographic Analysis: Further breakdown of Latin American remote patient monitoring into specific countries, the Middle East, and Africa remote patient monitoring into specific countries, and further breakdown of European remote patient monitoring into specific countries
Get the Full Remote Patient Monitoring (RPM) Market Report
Full forecast, segment splits, and company analysis for all Remote Patient Monitoring (RPM) Market.
- Canada Remote Patient Monitoring (RPM) Market
- US Remote Patient Monitoring (RPM) Market
- Germany Remote Patient Monitoring (RPM) Market
- France Remote Patient Monitoring (RPM) Market
- Italy Remote Patient Monitoring (RPM) Market
- Spain Remote Patient Monitoring (RPM) Market
- China Remote Patient Monitoring (RPM) Market
- Japan Remote Patient Monitoring (RPM) Market
- India Remote Patient Monitoring (RPM) Market
- Australia Remote Patient Monitoring (RPM) Market
- South Korea Remote Patient Monitoring (RPM) Market
- Brazil Remote Patient Monitoring (RPM) Market
- Mexico Remote Patient Monitoring (RPM) Market
- Saudi Arabia Remote Patient Monitoring (RPM) Market
- UAE Remote Patient Monitoring (RPM) Market
- South Africa Remote Patient Monitoring (RPM) Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report